Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
Research To Practice | Oncology Videos · Dr. Neil Love
November 19, 202456m 49s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:
- Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
- First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
- Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)
- Beyond the Guidelines Survey (35:36)
- Faculty Case Presentations (51:27)